68Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial - Takeaways - MDSpire

68Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial

  • By

  • Patrick Bowden

  • Andrew W. See

  • Kevin So

  • Nathan Lawrentschuk

  • Daniel Moon

  • Declan G. Murphy

  • Ranjit Rao

  • Alan Crosthwaite

  • Dennis King

  • Hodo Haxhimolla

  • Jeremy Grummet

  • Paul Ruljancich

  • Dennis Gyomber

  • Adam Landau

  • Nicholas Campbell

  • Mark Frydenberg

  • Lloyd M. L. Smyth

  • Skye Nolan

  • Stella M. Gwini

  • Dean P. McKenzie

  • June 2, 2021

  • 0 min

Share

  • 1

    One in three men with prostate cancer experiences recurrence within 10 years after radical prostatectomy, indicated by rising PSA levels.

  • 2

    68Ga-PSMA-PET imaging is more sensitive than conventional methods for detecting recurrent prostate cancer, influencing treatment strategies for many patients.

  • 3

    This study evaluates the outcomes of transponder-guided salvage radiotherapy to the prostate bed alone for patients with biochemical recurrence.

  • 4

    The primary endpoint is the rate of freedom from biochemical relapse following salvage radiotherapy, with secondary endpoints including toxicity and quality of life.

  • 5

    Patients with negative 68Ga-PSMA-PET results or positive findings limited to the prostate bed received targeted salvage radiotherapy without androgen deprivation therapy.

Original Source(s)

68Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial

  • by Patrick Bowden, Andrew W. See, Kevin So, Nathan Lawrentschuk, Daniel Moon, Declan G. Murphy, Ranjit Rao, Alan Crosthwaite, Dennis King, Hodo Haxhimolla, Jeremy Grummet, Paul Ruljancich, Dennis Gyomber, Adam Landau, Nicholas Campbell, Mark Frydenberg, Lloyd M. L. Smyth, Skye Nolan, Stella M. Gwini, Dean P. McKenzie

  • June 2, 2021

Related Content

Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on technique

Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer

Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review